middle.news
How Island Pharmaceuticals Secured FDA Backing and US Partnerships for Galidesivir
8:42am on Tuesday 27th of January, 2026 AEDT
•
Healthcare
Read Story
How Island Pharmaceuticals Secured FDA Backing and US Partnerships for Galidesivir
8:42am on Tuesday 27th of January, 2026 AEDT
Key Points
FDA confirms Galidesivir’s eligibility under Animal Rule and Priority Review Voucher
Master Service Agreement signed with Texas Biomed for critical non-human primate studies
Expanded US patent protection for COVID-19 use through 2042
Strengthened US government engagement via Todd Strategy Group and Medical Countermeasures Coalition
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE